Thomas Charles Heineman, Chief Medical Officer at Oncolytics Biotech Inc. ($ONCY), made one open market purchase of common shares in the last year, totaling about $10,000. His most recent buy occurred on February 12, 2026. This ranks him 4,277th out of nearly 5,000 insiders by purchase value, well below the average of $1.5 million across 3.3 transactions. He reported no open market sales during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | ONCOLYTICS BIOTECH INC | $ONCY | Heineman Thomas Charles | Chief Medical Officer | P | Common Shares | 12132 | $0.83 | 282,818.0000 | 80,020,131 | 4.48% | 0.02% |